DNTH Stock Price
Dianthus Therapeutics, Inc.
DNTH stock price is $75.26 (-2.99% on the day), giving Dianthus Therapeutics, Inc. a market cap of $4.34B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
DNTH Stock Overview
- Price
- $75.26
- Previous close
- $77.58
- Open
- $77.17
- Market cap
- $4.34B
- P/E ratio
- -26.7
- 52-week range
- $32.22 - $117.88
- 1-year price target
- $140.13
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 43
About Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. The company is developing DNTH103, a monoclonal antibody, which is in clinical-stage trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $75.26 | -3.0% | 342.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dianthus Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW